Trump unveils 100 percent tariff on drugs to push for pharmaceutical deals

President Trump announced a 100 percent tariff on pharmaceutical drugs as a negotiating tactic to lower medication costs in the United States. The Trump administration has previously signaled its intent to use tariffs as leverage to pressure pharmaceutical companies into reducing prices. The policy aims to incentivize drugmakers to strike deals with the White House on pricing, though economists and industry analysts question whether the approach will achieve its stated goal or instead increase costs for consumers and hospitals. The administration has framed aggressive tariff use as a central tool for renegotiating what it views as unfair trade relationships and inflated prices across multiple sectors. The full impact of the tariff threat on drug pricing negotiations and the pharmaceutical market remains unclear.